Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems
Launched by UNIVERSITAIR ZIEKENHUIS BRUSSEL · Dec 16, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
See the subsequent protocol sections.
Gender
MALE
Eligibility criteria
- • Inclusion criteria
- • young adult men (≥18 years)
- • diagnosis of cancer or hematological disorder during childhood (\<18 years)
- • high-risk gonadotoxic treatment received during childhood
- • at least one year after the last received genotoxic treatment
- • did/did not undergo a testicular biopsy procedure at a young age for fertility preservation
- • Exclusion criteria
- • - prepubertal patients and adolescents (\<18 years)
About Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel) is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution affiliated with the Vrije Universiteit Brussel, UZ Brussel integrates cutting-edge medical research with high-quality patient care. The hospital's multidisciplinary teams are dedicated to exploring novel therapeutic approaches and contributing to the development of evidence-based treatments, ensuring the highest standards of safety and efficacy in clinical research. With a strong focus on collaboration and knowledge dissemination, UZ Brussel plays a pivotal role in shaping the future of medicine and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Brussels, Flemish Brabant, Belgium
Patients applied
Trial Officials
Ellen Goossens, Prof. Dr.
Principal Investigator
Vrije Universiteit Brussel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials